ijms-logo

Journal Browser

Journal Browser

Effects of Natural Products on Neurological Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 43

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Sciences and Technology, Tel-Hai College, Tel-Hai 1220800, Israel
Interests: natural product discovery and chemistry; neuropharmacology and drug screening; oxidative stress mechanisms and antioxidant therapeutics; molecular neurobiology of synaptic function; medicinal plant bioactives; signal transduction pathways in neuronal survival; neuroinflammation modulation; structure–activity relationship studies; pharmacokinetics and blood–brain barrier delivery; translational neuroscience and in-vivo modeling

Special Issue Information

Dear Colleagues,

Neurological disorders—such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and related dementias—pose a growing global burden. These conditions share complex pathophysiological features, including oxidative stress, chronic neuroinflammation, mitochondrial dysfunction, and protein misfolding.

Conventional therapies provide symptomatic relief but do not halt neurodegeneration. Growing evidence indicates that natural products and their derivatives—including polyphenols, terpenoids, alkaloids, peptides, marine metabolites, cannabis-derived cannabinoids, and psychoactive tryptamines such as psilocybin—can modulate these pathways and confer neuroprotection. These compounds exert antioxidant and anti-inflammatory effects, activate pro-survival signaling cascades (e.g., PI3K/AKT and BDNF-TrkB-CREB), inhibit acetylcholinesterase activity, and reduce amyloid-β and Tau pathologies.

This Special Issue focuses on the effects of natural products on neurological diseases. We invite submissions on the following topics:

  • In vitro and in vivo studies, including animal models;
  • Isolation and characterization of neuroactive compounds;
  • Structure–activity relationships;
  • Pharmacokinetics and blood–brain barrier delivery;
  • Combination therapies.

We particularly welcome work addressing challenges such as bioavailability and clinical translation, with the ultimate goal of advancing safe, effective interventions against neurological disorders.

Dr. Maytal Shabat-Simon
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • neurodegenerative diseases
  • oxidative stress
  • neuroinflammation
  • amyloid β
  • TAU pathology
  • PI3K/AKT
  • BDNF-TrkB-CREB
  • phytochemicals
  • neuroprotection
  • cannabinoids
  • psilocybin/psilocyn
  • mitochondrial dysfunction
  • blood–brain barrier
  • high-throughput screening
  • animal models
  • structure–activity relationship
  • pharmacokinetics
  • bioavailability

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop